Diabetes Business Overview
FY2008 Revenue
Diabetes accounted for $1.0 billion, or 7%, of Medtronic's $13.5 billion in revenue in FY2008.
Diabetes is our fifth-largest business. For more than 25 years, we've been making it easier for people with diabetes to manage their glucose levels and live longer, healthier lives. A key milestone in that effort was the 1983 introduction of our insulin pump therapy.
We also developed the only integrated diabetes management systems that combine the power of insulin pump therapy with continuous glucose monitoring. Integrating these technologies is a major step toward the development of a "closed-loop" insulin delivery system that may one day mimic some functions of the human pancreas.
Our innovations reflect expertise in these key areas of diabetes management medical technology:
- Advanced insulin delivery systems1 that deliver life-saving insulin therapy. Medtronic is the number 1 insulin pump prescribed by doctors.
- Continuous glucose monitoring devices that monitor the body's glucose levels in real time.
- Data management software to help patients and their healthcare providers optimize diabetes management and improve quality of life.
References
- Important Safety Information for the Minimed Paradigm® Real-Time System